<DOC>
	<DOCNO>NCT01303601</DOCNO>
	<brief_summary>Olanzapine may antidepressant property olanzapine monotherapy show efficacy bipolar depressive episode retrospective study . However , prospective study monotherapy olanzapine . The investigator conduct randomized , placebo-controlled study test efficacy olanzapine monotherapy treatment depress phase bipolar disorder .</brief_summary>
	<brief_title>Efficacy Olanzapine Monotherapy Treatment Bipolar Ⅰ Depression</brief_title>
	<detailed_description>The study design double-blind randomized control trial , research assessor patient intend blind intervention status . The staff member perform assessment involve implement aspect intervention.68 patient randomize assigned 6 week olanzapine placebo . Medications provide double-blind fashion . The assessment include Montgomery-Asberg Depression Rating Scale , Young Mania Rating Scale , clinical Global Impressions-Severity Illness scale , Clinical Global Impressions-Improvement scale , response remission rate , Treatment Emergent Symptom Scale .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Outpatients clinical diagnosis bipolarⅠdisorder MADRS total score ≥ 20 CGIS rating ≥ 4 Normal result physical examination , laboratory electrocardiogram test Being take care guardians trial Pregnant lactate woman YMRS total score ≥ 15 Treatment olanzapine within 3 month prior study entry Retrospective history poor antidepressive response intolerance olanzapine Mental retardation Addictive disorder Diabetes mellitus Dyslipidaemia Cardiovascular diseases Hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Olanzapine</keyword>
	<keyword>Monotherapy</keyword>
	<keyword>bipolar Ⅰ depression</keyword>
</DOC>